DCF — CIVISTA MEDICAL CENTER
Enterprise Value: $16.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$16.4M
Enterprise Value
$0.8M
PV of Cash Flows
$15.6M
PV of Terminal Value
$25.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $159.5M | $5.5M | 3.0% | $-1.7M | $-1.5M |
| Year 2 | $164.3M | $7.3M | 4.0% | $-0.5M | $-0.4M |
| Year 3 | $169.2M | $9.2M | 5.0% | $0.8M | $0.6M |
| Year 4 | $174.3M | $10.3M | 6.0% | $1.5M | $1.0M |
| Year 5 | $179.5M | $11.1M | 6.0% | $1.8M | $1.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $16.4M. Terminal value accounts for 95% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$154.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.02923370958220384
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5